Search Results - "Maria D’Arco, Alfonso"

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi by Merli, Michele, Visco, Carlo, Spina, Michele, Luminari, Stefano, Ferretti, Virginia Valeria, Gotti, Manuel, Rattotti, Sara, Fiaccadori, Valeria, Rusconi, Chiara, Targhetta, Clara, Stelitano, Caterina, Levis, Alessandro, Ambrosetti, Achille, Rossi, Davide, Rigacci, Luigi, D'Arco, Alfonso Maria, Musto, Pellegrino, Chiappella, Annalisa, Baldini, Luca, Bonfichi, Maurizio, Arcaini, Luca

“…A specific prognostication score for hepatitis C virus-positive diffuse large B-cell lymphomas is not available. For this purpose, the Fondazione Italiana…”
Get full text

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial by Platzbecker, Uwe, Avvisati, Giuseppe, Cicconi, Laura, Thiede, Christian, Paoloni, Francesca, Vignetti, Marco, Ferrara, Felicetto, Divona, Mariadomenica, Albano, Francesco, Efficace, Fabio, Fazi, Paola, Sborgia, Marco, Di Bona, Eros, Breccia, Massimo, Borlenghi, Erika, Cairoli, Roberto, Rambaldi, Alessandro, Melillo, Lorella, La Nasa, Giorgio, Fiedler, Walter, Brossart, Peter, Hertenstein, Bernd, Salih, Helmut R, Wattad, Mohammed, Lübbert, Michael, Brandts, Christian H, Hänel, Mathias, Röllig, Christoph, Schmitz, Norbert, Link, Hartmut, Frairia, Chiara, Pogliani, Enrico Maria, Fozza, Claudio, D'Arco, Alfonso Maria, Di Renzo, Nicola, Cortelezzi, Agostino, Fabbiano, Francesco, Döhner, Konstanze, Ganser, Arnold, Döhner, Hartmut, Amadori, Sergio, Mandelli, Franco, Ehninger, Gerhard, Schlenk, Richard F, Lo-Coco, Francesco

“…Purpose The initial results of the APL0406 trial showed that the combination of all- trans-retinoic acid (ATRA) and arsenic trioxide (ATO) is at least not…”
Get full text

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial by Cicconi, Laura, Platzbecker, Uwe, Avvisati, Giuseppe, Paoloni, Francesca, Thiede, Christian, Vignetti, Marco, Fazi, Paola, Ferrara, Felicetto, Divona, Mariadomenica, Albano, Francesco, Efficace, Fabio, Sborgia, Marco, Di Bona, Eros, Breccia, Massimo, Borlenghi, Erika, Cairoli, Roberto, Rambaldi, Alessandro, Melillo, Lorella, La Nasa, Giorgio, Fiedler, Walter, Brossart, Peter, Hertenstein, Bernd, Salih, Helmut R., Annibali, Ombretta, Wattad, Mohammed, Lubbert, Michael, Brandts, Christian H., Hanel, Mathias, Rollig, Christoph, Schmitz, Norbert, Link, Hartmut, Frairia, Chiara, Fozza, Claudio, Maria D’Arco, Alfonso, Di Renzo, Nicola, Cortelezzi, Agostino, Fabbiano, Francesco, Dohner, Konstanze, Ganser, Arnold, Dohner, Hartmut, Amadori, Sergio, Mandelli, Franco, Voso, Maria Teresa, Ehninger, Gerhard, Schlenk, Richard F., Lo-Coco, Francesco

Get full text

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape by Conte, Mariarosaria, Dell'Aversana, Carmela, Benedetti, Rosaria, Petraglia, Francesca, Carissimo, Annamaria, Petrizzi, Valeria Belsito, D'Arco, Alfonso Maria, Abbondanza, Ciro, Nebbioso, Angela, Altucci, Lucia

“…Histone deacetylase 2 (HDAC2) is overexpressed or mutated in several disorders such as hematological cancers, and plays a critical role in transcriptional…”
Get full text

First Results of the Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients by Chiaretti, Sabina, Vitale, Antonella, Elia, Loredana, Albino, Silvana, Piciocchi, Alfonso, Fazi, Paola, Di Raimondo, Francesco, Fornaro, Antonella, Fabbiano, Francesco, D’Arco, Alfonso Maria, Martinelli, Giovanni, Ronco, Francesca, Santoro, Lidia Edwige, Cascavilla, Nicola, Galieni, Piero, Tedeschi, Alessandra, Sica, Simona, Di Renzo, Nicola, Melpignano, Angela, Carella, Angelo Michele, Ferrara, Felicetto, Vignetti, Marco, Foa, Robin

“…▪ Introduction: Ph+ ALL management has changed since the introduction of tyrosine kinase inhibitors (TKI). In the GIMEMA LAL 1509 protocol for adult Ph+ ALL,…”
Get full text

Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Updated Results and Refined Genetic-Based Prognostic Stratification by Chiaretti, Sabina, Vitale, Antonella, Elia, Loredana, Fedullo, Anna Lucia, Albino, Silvana, Piciocchi, Alfonso, Fazi, Paola, Di Raimondo, Francesco, Fornaro, Antonella, Fabbiano, Francesco, D'Arco, Alfonso Maria, Martinelli, Giovanni, Ronco, Francesca, Santoro, Lidia Edwige, Cascavilla, Nicola, Galieni, Piero, Tedeschi, Alessandra, Sica, Simona, Di Renzo, Nicola, Melpignano, Angela, Carella, Angelo Michele, Ferrara, Felicetto, Vignetti, Marco, Foà, Robin

“…Introduction: Management of Ph+ ALL has changed since the introduction of tyrosine kinase inhibitors (TKI). We previously reported the preliminary findings of…”
Get full text

Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients by D'Arena, Giovanni, Califano, Catello, Annunziata, Mario, Tartarone, Alfredo, Capalbo, Silvana, Villani, Oreste, Amendola, Giovanni, Pietrantuono, Giuseppe, Ferrara, Felicetto, Pinto, Antonio, Musto, Pellegrino, D'Arco, Alfonso Maria, Cascavilla, Nicola

“…Warm‐type idiopathic autoimmune hemolytic anemia (AIHA) is a relatively common hematologic disorder resulting from autoantibody production against red blood…”
Get full text

Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia by D'Arena, Giovanni, Laurenti, Luca, Capalbo, Silvana, D'Arco, Alfonso Maria, De Filippi, Rosaria, Marcacci, Gianpaolo, Di Renzo, Nicola, Storti, Sergio, Califano, Catello, Vigliotti, Maria Luigia, Tarnani, Michela, Ferrara, Felicetto, Pinto, Antonio

“…Autoimmune hemolytic anemia (AIHA) is a well‐known complication of chronic lymphocytic leukemia (CLL). In recent years the anti‐CD20 monoclonal antibody…”
Get full text

5-Azacytidine for the Treatment of Acute Myeloid Leukemia: A Retrospective, Multicenter Study of 55 Patients by Maurillo, Luca, Spagnoli, Alessandra, Genuardi, Mariella, Lunghi, Monia, Di Renzo, Nicola, D'Arco, Alfonso Maria, Mele, Giuseppe, Levis, Alessandro, Gozzini, Antonella, Petrini, Mario, Mianulli, Manuela, Sanpaolo, Grazia, Santagostino, Alberto, Pietrantuono, Giuseppe, D'Auria, Fiorella, Ferrero, Dario, Gaidano, Gianluca, Ferrara, Felicetto, Venditti, Adriano, Leone, Giuseppe, Santini, Valeria, Musto, Pellegrino

“…5-Azacytidine (AZA) is an hypomethylating agent approved in US for the treatment of all FAB subtypes of myelodysplastic syndromes (MDS). Some recent reports…”
Get full text

Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series by Platzbecker, Uwe, Avvisati, Giuseppe, Ehninger, Gerhard, Cicconi, Laura, Thiede, Christian, Ferrara, Felicetto, Orlando, Sonia Maria, Vignetti, Marco, Specchia, Giorgina, Sborgia, Marco, Di Bona, Eros, Breccia, Massimo, Cerqui, Elisa, Döhner, Konstanze, Fiedler, Walter, von Lilienfeld-Toal, Marie, Hertenstein, Bernd, Salih, Helmut R., Wattad, Mohammed, Lübbert, Michael, Brandts, Christian H., Hänel, Mathias, Schmitz, Norbert, Link, Hartmut, Divona, Mariadomenica, Frairia, Chiara, Pogliani, Enrico Maria, Fozza, Claudio, D’Arco, Alfonso Maria, Di Renzo, Nicola, Cortelezzi, Agostino, Fabbiano, Francesco, Fazi, Paola, Kullmer, Johannes, Aulitzky, Walter E., Krause, Stefan W., Salwender, Hans, Schäfer-Eckart, Kerstin, Radsak, Markus P., Ganser, Arnold, Döhner, Hartmut, Amadori, Sergio, Mandelli, Franco, Schlenk, Richard F., Lo-Coco, Francesco

“…▪ Background: We recently showed that the combination of ATRA and arsenic trioxide (ATO) is at least not inferior and possibly superior to standard ATRA and…”
Get full text

MDS-391: Role of Erythropoiesis-Stimulating Agents (ESAs) in Supportive Care of Low-Risk Myelodysplastic Syndromes by Cerchione, Claudio, Alfinito, Fiorella, Soriente, Ilaria, D'Arco, Alfonso Maria, Danise, Paolo, Cerciello, Giuseppe, Pane, Fabrizio, Martinelli, Giovanni

“…Erythropoiesis-stimulating agents (ESAs) are the frontline treatment in low-risk anemic MDS patients, and employment of this therapy in the earlier stage of…”
Get full text

Azacitidine for the Treatment of Lower Risk Myelodysplastic Syndromes: A Retrospective Study of 74 Patients Enrolled in an Italian Named Patient Program by MUSTO, Pellegrino, MAURILLO, Luca, SPAGNOLI, Alessandra, GOZZINI, Antonella, RIVELLINI, Flavia, LUNGHI, Monia, VILLANI, Oreste, ALOE-SPIRITI, Maria Antonietta, VENDITTI, Adriano, SANTINI, Valeria

“…Azacitidine induces responses and prolongs overall survival compared with conventional care regimens in patients who have high-risk myelodysplastic syndromes…”
Get full text

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study by Tacchetti, Paola, Pantani, Lucia, Patriarca, Francesca, Petrucci, Maria Teresa, Dozza, Luca, Galli, Monica, Di Raimondo, Francesco, Crippa, Claudia, Boccadoro, Mario, Barbato, Simona, Tosi, Patrizia, Narni, Franco, Montefusco, Vittorio, Testoni, Nicoletta, Spadano, Antonio, Terragna, Carolina, Pescosta, Norbert, Marzocchi, Giulia, Cellini, Claudia, Ronconi, Sonia, Gobbi, Marco, Catalano, Lucio, Lazzaro, Antonio, De Sabbata, Giovanni, Cangialosi, Clotilde, Ciambelli, Fabrizio, Musto, Pellegrino, Elice, Francesca, Cavo, Michele, Fanin, Renato, Foa', Roberto, Rambaldi, Alessandro, Di Raimondo, Francesco, Rossi, Giuseppe, Boccadoro, Mario, Leoni, Pietro, Corradini, Paolo, Torelli, Giuseppe, Fioritoni, Giuseppe, Cortelazzo, Sergio, Lambertenghi Deliliers, Giorgio, La Nasa, Giorgio, Zaccaria, Alfonso, De Fabritiis, Paolo, Cascavilla, Nicola, Bosi, Alberto, Semenzato, Gianpietro, Gugliotta, Luigi, Gherlinzoni, Filippo, Angelucci, Emanuele, Martelli, Massimo Fabrizio, Petti, Maria Concetta, Leone, Giuseppe, Carella, Angelo Michele, Ciceri, Fabio, Santoro, Armando, Ferrara, Felicetto, Nobile, Francesco, D'Arco, Alfonso Maria, Levis, Alessandro, Guardigni, Luciano, Musto, Pellegrino, Fattori, Pier Paolo, Galieni, Piero, Morandi, Sergio, Amadori, Dino, Gobbi, Marco, Rotoli, Bruno, Mirto, Salvatore, Lazzaro, Antonio, Paladini, Giorgio, Mozzana, Ruggero, Pinotti, Graziella, Rodeghiero, Francesco, Cantore, Nicola, Pavone, Vincenzo, Pogliani, Enrico Maria, Liberati, Anna Marina, Majolino, Ignazio, Amadori, Sergio, Lauria, Francesco, Aglietta, Massimo, Quarta, Giovanni, Storti, Sergio, Morabito, Fortunato, Capalbo, Silvana Franca, Gianni, Alessandro Massimo, Mettivier, Vincenzo, Rizzoli, Vittorio, Bernasconi, Carlo, Visani, Giuseppe, Pizzuti, Michele, La Verde, Giacinto, Avvisati, Giuseppe, Longinotti, Maurizio, Gallo, Eugenio, Dammacco, Franco, Russo, Domenico, Bacigalupo, Andrea, Musolino, Caterina

“…The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD)…”
Get full text

Feasibility and efficacy of dose‐dense and dose‐intense ABVD for high‐risk patients with advanced Hodgkin lymphoma by D'Arco, Alfonso Maria, Califano, Catello, Barone, Lucia, Belsito Petrizzi, Valeria, Iovino, Vincenzo, Langella, Maria, Maglione, Valentina, Rivellini, Flavia, De Lorenzo, Sonya

Get full text

Lenalidomide in Combination with Bendamustine for Patients with Chemorefractory Hodgkin Lymphoma: Final Results of the Leben Multicenter Phase 1/2 Study by Pinto, Antonello, Pavone, Vincenzo, Angrilli, Francesco, Saggese, Mariangela, Crisci, Stefania, Patti, Caterina, Zinzani, Pier Luigi, D'Arco, Alfonso Maria, Cavalieri, Elena, Guarini, Attilio, Spina, Michele, Carlino, Daniela, Falorio, Simona, Morelli, Emanuela, Arcamone, Manuela, Frigeri, Ferdinando, De Chiara, Annarosaria, De Filippi, Rosaria, Corazzelli, Gaetano

“…Background Improving strategies for patients (pts) with relapsed/refractory (R/R) Hodgkin lymphoma (HL) who fail stem cell transplantation (SCT) or are…”
Get full text

Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency by Arcioni, Francesco, Roncadori, Andrea, Di Battista, Valeria, Tura, Sante, Covezzoli, Anna, Cundari, Sante, Mecucci, Cristina, Abbadessa, Antonio, Alterini, Renato, Santini, Valeria, Cantonetti, Maria, Buccisano, Francesco, Bacigalupo, Andrea, Sessarego, Mario, Tonso, Anna, Ferrero, Dario, D'Ardia, Stefano, Tarella, Corrado, Cascavilla, Nicola, Bassan, Renato, Sancetta, Rosaria, Cortelezzi, Agostino, Reda, Gianluigi, Maria D'Arco, Alfonso, De Fabritiis, Paolo, Di Renzo, Nicola, Falini, Brunangelo, Alimena, Giuliana, Avanzini, Paolo, Ilariucci, Fiorella, Iuliano, Francesco, La Nasa, Giorgio, Caocci, Giovanni, Defina, Marzia, Latte, Giancarlo, Palmas, Angelo, Levis, Alessandro, Leone, Giuseppe, Teresa Voso, Maria, Leoni, Pietro, Poloni, Antonella, Fozza, Claudio, Crugnola, Monica, Montanaro, Marco, Spedini, Pierangelo, Lanza, Francesco, Pizzuti, Michele, Pane, Fabrizio, Paolini, Rossella, Borin, Lorenza, Rambaldi, Alessandro, Rossi, Giuseppe, Maria Pelizzari, Anna, Russo, Domenico, D'Emilio, Anna, Ruggeri, Marco, Semenzato, Giampietro, Specchia, Giorgina, Tagariello, Giuseppe, Sartori, Roberto, Testore, Franco, Ciravegna, Giorgio, Marasca, Roberto, Cimarosto, Lorella, Fontanive, Orietta, Visani, Giuseppe

“…Objective The most typical cytogenetic aberration in myelodysplastic syndromes is del(5q), which, when isolated, is associated with refractory anaemia and good…”
Get full text

5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program by Musto, Pellegrino, Maurillo, Luca, Spagnoli, Alessandra, Gozzini, Antonella, Rivellini, Flavia, Tatarelli, Caterina, Lunghi, Monia, Fili, Carla, Orciuolo, Enrico, Ciuffreda, Lucia, Vigna, Ernesto, Cioppa, Paola Della, Candoni, Anna, Ferrero, Dario, Palmieri, Salvatore, Palumbo, Giuseppe, Di Renzo, Nicola, Oliva, Esther, Sanpaolo, Grazia, Pastore, Domenico, Tonso, Anna, Santagostino, Alberto, Rocco, Stefano, Villani, Oreste, D'Auria, Fiorella, D'Arco, Alfonso Maria, Gaidano, Gianluca, Galimberti, Sara, Russo, Domenico, Venditti, Adriano, Aloe-Spiriti, Maria Antonietta, Leone, Giuseppe, Santini, Valeria

“…5-azacytidine (AZA) significantly prolonged overall survival in higher-risk patients with myelodysplastic syndromes (MDS) in a large, international,…”
Get full text

Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia by Tedeschi, Alessandra, Rossi, Davide, Coscia, Marta, Vismara, Eleonora, Petrizzi, Valeria Belsito, Orlandi, Ester, Cascavilla, Nicola, Scarfò, Lydia, Motta, Marina, Vitale, Candida, Ricci, Francesca, De Paoli, Lorenzo, D'Arco, Alfonso Maria, Gallamini, Andrea, Gaidano, Gianluca, Morra, Enrica, Massaia, Massimo, Montillo, Marco

“…Abstract 2898 Notwithstanding the improved results with first-line therapy, CLL remains incurable, and patients are destined to relapse after primary…”
Get full text

Deferasirox Chelation Therapy in Transfusion Dependent MDS Patients. Final Report From the Gimema MDS0306 Prospective Trial by Angelucci, Emanuele, Santini, Valeria, Tucci, Anna Angela Di, Finelli, Carlo, Cantore, Nicola, Quarta, Giovanni, D'Arco, Alfonso Maria, Cascavilla, Nicola, Saglio, Giuseppe, Levis, Alessandro, Pettinau, Martina, Caocci, Giovanni, Morra, Enrica, Vallisa, Daniele, Latte, Giancarlo, Piciocchi, Alfonso, Bontempi, Katia, Vignetti, Marco, Tura, Sante

“…Abstract 425 FDA and EMA have approved Deferasirox for iron chelation therapy for transfusion dependent MDS patients after a limited experience in selected MDS…”
Get full text

Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi by Zaja, Francesco, Salvi, Flavia, Franceschetti, Silvia, Gaidano, Gianluca, Ladetto, Marco, Zanni, Manuela, Pica, Gian Matteo, Carella, Angelo Michele, Chiappella, Annalisa, Volpetti, Stefano, Zinzani, Pier Luigi, D'Arco, Alfonso Maria, Evangelista, Andrea, Tucci, Alessandra, Piccaluga, Pier Paolo, Pileri, Stefano A., Fanin, Renato, Levis, Alessandro

“…Histone deacetylases (DACs) are involved in chromatin structure regulation and function. Treatment with DACs inhibitors leads to the activation or repression…”
Get full text